Feasibility of Semi-Permanent Tattoo for Treatment Alignment in Radiation Therapy
Sponsor: Ephemeral Solutions Inc.
A NA clinical study on Cancer, Treatment-Related and Tattoo; Pigmentation, this trial is completed. The trial is conducted by Ephemeral Solutions Inc. and has accumulated 8 data snapshots since 2022. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
8 versions recorded-
Dec 2024 — Present [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Sep 2024 — Dec 2024 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Jun 2024 — Jul 2024 [monthly]
Active Not Recruiting NA
-
Jul 2023 — Jun 2024 [monthly]
Active Not Recruiting NA
▶ Show 3 earlier versions
-
Apr 2023 — Jul 2023 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2022 — Apr 2023 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Mar 2022 — Sep 2022 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Ephemeral Solutions Inc.
- Henry Ford Health System
For direct contact, visit the study record on ClinicalTrials.gov .